The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The global Natural Killer Cells Therapeutics market was valued at US$ 350 million in 2023 and is anticipated to reach US$ 1012.3 million by 2030, witnessing a CAGR of 16.4% during the forecast period 2024-2030.
A significant driver in the Natural Killer Cells Therapeutics market is the growing interest in immunotherapy approaches for cancer treatment. Natural killer (NK) cell-based therapeutics have emerged as a promising strategy to harness the body's immune system to combat cancer. However, a notable challenge in this market is the need for scalability and manufacturing standardization. Ensuring that NK cell therapies can be produced reliably at scale while addressing challenges related to cell expansion, quality control, and patient-specific manufacturing poses a significant challenge. Researchers and manufacturers must invest in technology advancements, quality assurance processes, and regulatory compliance to make NK cell-based therapeutics widely accessible and consistently effective in the fight against cancer.
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cells Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cells Therapeutics.
Report Scope
The Natural Killer Cells Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Natural Killer Cells Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cells Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company (Partial List)
- Affimed
- Celgene
- Fate Therapeutics
- Fortress Biotech
- Glycostem Therapeutics
- Innate Pharma
- Nantkwest
- Nkarta Therapeutics
- NKT Therapeutics
- Ziopharm Oncology
Segment by Type
- NK Cell Therapies
- NK Cell Directed Antibodies
Segment by Application
- Cancer
- Gastrointestinal Diseases
- Immunoproliferative Disorders
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cells Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cells Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Immunoproliferative Disorders
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cells Therapeutics Market Perspective (2019-2030)
2.2 Natural Killer Cells Therapeutics Growth Trends by Region
2.2.1 Global Natural Killer Cells Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Natural Killer Cells Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Natural Killer Cells Therapeutics Market Dynamics
2.3.1 Natural Killer Cells Therapeutics Industry Trends
2.3.2 Natural Killer Cells Therapeutics Market Drivers
2.3.3 Natural Killer Cells Therapeutics Market Challenges
2.3.4 Natural Killer Cells Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cells Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue
3.4 Global Natural Killer Cells Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2023
3.5 Natural Killer Cells Therapeutics Key Players Head office and Area Served
3.6 Key Players Natural Killer Cells Therapeutics Product Solution and Service
3.7 Date of Enter into Natural Killer Cells Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cells Therapeutics Breakdown Data by Type
4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2025-2030)
5 Natural Killer Cells Therapeutics Breakdown Data by Application
5.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Natural Killer Cells Therapeutics Market Size (2019-2030)
6.2 North America Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
6.4 North America Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer Cells Therapeutics Market Size (2019-2030)
7.2 Europe Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
7.4 Europe Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Natural Killer Cells Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Natural Killer Cells Therapeutics Market Size (2019-2030)
9.2 Latin America Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Natural Killer Cells Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Affimed
11.1.1 Affimed Company Detail
11.1.2 Affimed Business Overview
11.1.3 Affimed Natural Killer Cells Therapeutics Introduction
11.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.1.5 Affimed Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene Natural Killer Cells Therapeutics Introduction
11.2.4 Celgene Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.2.5 Celgene Recent Development
11.3 Fate Therapeutics
11.3.1 Fate Therapeutics Company Detail
11.3.2 Fate Therapeutics Business Overview
11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction
11.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.3.5 Fate Therapeutics Recent Development
11.4 Fortress Biotech
11.4.1 Fortress Biotech Company Detail
11.4.2 Fortress Biotech Business Overview
11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction
11.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.4.5 Fortress Biotech Recent Development
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Detail
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.5.5 Glycostem Therapeutics Recent Development
11.6 Innate Pharma
11.6.1 Innate Pharma Company Detail
11.6.2 Innate Pharma Business Overview
11.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction
11.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.6.5 Innate Pharma Recent Development
11.7 Nantkwest
11.7.1 Nantkwest Company Detail
11.7.2 Nantkwest Business Overview
11.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction
11.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.7.5 Nantkwest Recent Development
11.8 Nkarta Therapeutics
11.8.1 Nkarta Therapeutics Company Detail
11.8.2 Nkarta Therapeutics Business Overview
11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction
11.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.8.5 Nkarta Therapeutics Recent Development
11.9 NKT Therapeutics
11.9.1 NKT Therapeutics Company Detail
11.9.2 NKT Therapeutics Business Overview
11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction
11.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.9.5 NKT Therapeutics Recent Development
11.10 Ziopharm Oncology
11.10.1 Ziopharm Oncology Company Detail
11.10.2 Ziopharm Oncology Business Overview
11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction
11.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2019-2024)
11.10.5 Ziopharm Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
